Thursday, September 24, 2026

linkedIn

I went 12 rounds with Mr Chemo. Came out pretty well, but some possible complications. Constant wait for the next step!

23 Sep 2026 7 Comments

Post-Chemo-side-effects-summary-23-Sep-2026.jpg

 

Hello and welcome to my post-chemo update on my cancer/chemo journey. For the story to date, see links to articles below.  

(Recapping the story so far)

In early December 2025 I received a positive bowel cancer screen (free government test) out of the blue (ie no symptoms or any other indications); spent the rest of December doing tests, scans, colonoscopy, etc; had surgery in early January 2026 to remove left side of large intestine, plus appendix, lymph nodes, and surrounding tissues.

Post-op biopsies and tests confirmed ‘stage 3’ cancer, meaning it was at ‘advanced’ stage but ‘localised’ to the surrounding areas, therefore a chance there is more cancer in there somewhere. To kill off any rogue cancers that got away, did 12 fortnights of chemotherapy from February to August.

Chemo program:

    • In hospital on every second Wednesday for about 4 hours getting the initial drugs and drips. The drugs were delivered are via a titanium port implanted in my chest, which has a catheter going up my neck into the jugular vein then down into the heart.
  •  
    • The next 48 hours I am on a chemo drip from a bottle I carry around in a bum bag with a tube plugged into the port in my chest. (A bit tricky at first getting used to showering, changing, sleeping with the drip attached 24/7, but you get used to it.)
  •  
    • Back in hospital on Fridays to unplug the drip and flush the port.
  •  
    • A few days rest and recovery, then a week to get fit and ready for the next round.
  •  
    • Repeat for 12 fortnights, with blood tests and oncologist consults before/after each round.

Chemo SIDE EFFECTS:

Chemo is different for everyone. I tracked 18 different side effects from head to toe – literally. Impacts ranged from weird, to annoying, to painful. (The only really painful, disruptive one was mouth ulcers).

Various side effects came and went at different times. Some were random, some were constant, some were temporary, and several related to cold temperatures in particular. (Hint: I would recommend chemo in winter!)

Some started literally from the first hour in the chair with the first drip on the first day. Others only appeared after several months. Some lasted only a few rounds then cleared up. Others are still with me a month after the last round.

Fortunately nothing too debilitating. None of the horror stories that afflicted many of the chemo patients I met or heard about during the journey. I was able to eat, sleep and exercise pretty well throughout.

Some side effects are still with me. The main annoying one is loss of feeling in toes and balls of feet, which affects walking and rules out running. Also still have partial loss of taste, some tongue disfunction (affects speech), and loss of feeling in finger tips. (Also, my fingerprints are gone, so am considering taking up a life of crime!)

Overall, I got through with only minor disruption to daily life. Certainly better than I had expected at the outset. I have been lucky, but I have tried to keep fit and active.

I am also lucky that Royal North Shore Hospital is a 10 minute walk from home, and it is a hub for dozens of related medical practices, clinics, labs, specialists, etc.

OUTCOMES – did the chemo work?

I had a CT scan before surgery, another mid-way through chemo (May), and after the end (September). The May (mid-way) CT gave a conditional ‘all clear’, but noted a couple of areas to watch - one spot on the liver and another in the right lung.

The September (post-chemo) CT showed the growth in the lymph node in the right lung had grown from 9mm to 15mm.

So the next step was a PET scan (last week), which showed up three areas my oncologist described as ‘mildly hot’ activity, including the growth in the lymph node in the right lung at 17mm. All three ‘mildly hot’ areas were on the right side torso, the same side as the original cancer.

The good news is that my oncologist seems fairly confident the hot spots are not too serious. So the next step is more ultra-sounds and biopsies.

Currently waiting to book those in, and then the wait for the results.

Even if/when I get the ‘all clear’ – I will have regular scans and tests every three months or so to see if anything pops up.

Always waiting for the next step!

‘Till next time – stay healthy and don’t put off those free government cancer screening tests!

 

NB. Please note that these are just my personal observations and experiences from a sample of one. Every patient is different, every cancer is different, and every chemo program is different. I have talked to several friends and relatives who have gone through their own cancer journeys and their ranges of experiences and side effects have been many and varied.

Related Articles

7 Comments

Existing Comments

You are still here and doing what you love when you can. Thats a great result. We are fortunate to have access to world class clinicians and treatment resources.

Your first hand reporting and stoicism is a beacon to us all.

Well done and keep it up!

J

Justin
September 23, 2026

Good on you mate, I admire your attitude and intellect.

Edward Hack
September 23, 2026

Thank you very much for sharing this very detailed picture. I followed your early progress online and I’m extremely pleased that you have continued to record the details. As you say everyone’s progress through this journey is unique but it’s comforting to hear from someone who is ahead of you. I’m amazed that you have been able to continue with your professional life through this time. Best wishes.

Brian
September 23, 2026

Well done to get through the12 rounds and being prepared to tell us all about your journey through such tough times . So important to prompt others to get regular checks.
It sounds like you still have further challenges coming up , for which I, and I am sure and other readers, will be wishing you well and silently offering you support .
I have forgotten what type of music you enjoy but hope listening to some of it will help you through the next rounds with Mr Chemo .
Keep up the fight

Geoff Stearn

Geoff Stearn
September 23, 2026

All the best with your ongoing health journey. Your documentation is incredible! Your bravery inspiring...

David
September 23, 2026

Ashley, thanks for your unfiltered sharing, explaining how this experience is appearing in your life, your body and your mind. Mate, if in this life time, it's my fate to endure such a challenge, I hope I would be able to muster the bravely, the positivity and clarity of mind you live in a state of life as you do. I and thousands of others who follow you continue to send thoughts of genuine care and wishes of healing and strength. With love in my heart, Rob

Rob Carrigan
September 23, 2026

Ashley, congratulations on going the full 12 rounds with Mr Chemo and coming out the other side still standing, still exercising and still writing with that trademark wry humour.

Only you could turn a chemo program into a well-organised data set with 18 side effects tracked from head to toe, and I suspect your oncologist has never had a patient who treated their treatment with such analytical rigour.

I had a good laugh at the fingerprint line, although I'd suggest you stick with markets analysis as your career of choice because you're far too honest for a life of crime.

I can imagine the waiting is the hardest part, especially for someone who has spent a lifetime making sense of uncertainty for the rest of us, so I'm glad your oncologist is feeling fairly confident, and I'll be hoping the biopsies bring you the news you want.

Thank you for being so open about the whole journey, because your reminder not to put off those free screening tests may well end up saving a few lives among your readers.

Keep up the fight, mate, and look after those toes

Michael Yardney
September 23, 2026

Leave a Reply

Ashley Owen

 

Please subscribe to my Newsletter, connect on LinkedIn, or follow me on Twitter X 

 

Experiences


Director/Principal, Owen Analytics Pty Ltd (current)

Investment Markets Research & Analytics, Portfolio Construction & Management, Corporate Finance, Venture Capital, M&A, and IPOs. Investment Committee membership, consulting to advice firms and financial institutions.

Co-founder & Regular Contributor, Firstlinks (current)

Co-founder of Australia's leading investment and superannuation newsletter and website for industry professionals and investors.

Non-exec Director, Third Link Investment Managers (current)

Leading Australian equities fund-of-funds that donates all management fees to Australian charities. The fund has donated in excess of $21m to a range of Australian chartities since inception in 2008. 

Chief Investment Officer, Stanford Brown (past)

Responsible for managing over $2 billion AUM in multi-asset class portfolios and discretionary accounts at a privately-owned advice practice.

Director & Joint CEO at Philo Capital Advisers Pty Ltd (past)

Specialises in investment portfolio construction & management, multi-asset class asset allocation, and global macro strategies.

Check out my full bio here

“What sets Ashley Owen’s analysis apart from investment banks and the financial press is his deep fact-based understanding of long-term financial data, rather than getting caught up on the daily noise over issues that may generate trades or sell newspapers today, but will be irrelevant and misleading two years from now.” 

Hugh Dive, CFA. Chief Investment Officer, Atlas Funds Management, and frequent expert commentator quoted in the AFR.

“Ashley is one of the best writers and thinkers on financial markets in Australia. His unique analysis and research is always fact-based and insightful, not the usual uninformed market noise and waffle that infects the mainstream financial media.”

Graham Hand - Editorial Director of Morningstar Australia, including Founder/Managing Editor of FirstLinks, Australia’s leading newsletter and publishing service on wealth management, superannuation, and personal finance.

“Ashley has the rare ability to ground insightful analysis in solid data and to present it in readily understandable ways. His wry, detached style and focus on the long term is rare and willingness to share a lifetime of learning and thinking appreciated by all who come to know him.”

Toby Potter - Chair, Institute of Managed Account Professionals (‘IMAP’), the peak industry body for the discretionary managed accounts industry in Australia, representing investment managers,  advisers, Managed Account providers, and technology companies. It is the primary thought-leader for the industry in Australia, and provides training and industry events and conferences.

‘For many years, Ashley has been my go-to source of information and analysis on what’s going on in financial markets and why.’

“Ashley has an encyclopaedic knowledge of the markets – I call him Mr Google!”

Noel Whittaker, AM – Australia’s best-known personal finance writer, columnist, and media commentator for the past three decades. He has written more than 20 books on personal finance, his regular columns on personal finance are published in almost every major Australian newspaper, and he appears regularly on radio and TV as an expert on finance and investing.

“Over the past 20 years, Ashley has been an invaluable assistance to me, as a reliable source of unbelievably strong and interesting data, and many good investment ideas.” 

"The depth and quality of Ashley’s research and analysis of investment markets is the best in the business.”

Dr Don Stammer - Australia’s most respected economic writer, commentator, and speaker for the past 40 years, with a distinguished career including the Reserve Bank of Australia, Chief Economist at Deutsche Bank Australia for 21 years, chair of nine ASX companies, plus numerous non-listed and not-for-profit boards.

“Ashley’s unique fact-based analyses and insights into Australian and global markets are always worth reading. He has an incredibly deep and comprehensive store of financial markets data.”

Chris Cuffe, AO – One of Australia’s best known and most experienced investment managers – former CEO of industry giants Colonial First State, then Challenger Financial; founder and Chair of Australian Philanthropic Services, and Third Link Growth Fund; current/former chair, director and/or investment committee member of numerous funds including UniSuper, Argo Investments, Hearts and Minds Investments, Paul Ramsay Foundation, and many others.

"I read all of Ashley's research on financial and economic issues. His data resources, deep knowledge, and original analysis put him in a class of his own."

Ian Macfarlane AC - Former Governor, Reserve Bank of Australia (Australia's central bank), 1996-2006. Former Director, Woolworths, Leighton Holdings, and ANZ Bank. Also on the International Advisory Boards of Goldman Sachs (2007-2016),  the China Banking Regulatory Commission (2011-2014), and director of the Lowy Institute for International Policy (2004-2017).

Copyright © 2026 Owen Analytics

About Ashley Owen | Terms and Conditions | Privacy Policy | Archive | Disclaimer

The information contained in this document relates to historical, factual events and returns, and contains general commentary and observations about financial markets, asset classes, and asset allocation. This document, or any part thereof, does not, and is not intended to, constitute investment advice, or financial advice, or financial product advice, in any jurisdiction in which it is published, re-published or read. It does not recommend, encourage, or influence readers to buy, hold, sell, or deal in any financial product or security. Where securities of financial products are mentioned, it is purely for the purposes of illustration, context, and/or education, and not intended to influence anyone to buy, hold, sell, or deal in it. The information is current when written. All reasonable measures are taken to ensure its accuracy at the time of publication, but the author accepts no responsibility or liability for any errors or omissions. This document is only provided to, and intended for, holders of Australian Financial Services Licences. It should not be used or relied upon by any person or entity other than a duly licenced AFSL holder, or authorised representative thereof. The author receives no benefit, financial or otherwise, from any product provider, or product issuer, or any other firm involved directly or indirectly in the provision or services in or to financial markets or industries, whether mentioned in the report or not. Any opinions expressed by the author are his alone, and are intended for the purposes of education.